Literature DB >> 21117028

CDC28 protein kinase regulatory subunit 1B (CKS1B) expression and genetic status analysis in oral squamous cell carcinoma.

Gemma Martín-Ezquerra1, Rocío Salgado, Agustí Toll, Teresa Baró, Sergi Mojal, Mireia Yébenes, Ma Pilar Garcia-Muret, Francesc Solé, Francesc Alameda Quitllet, Blanca Espinet, Ramon M Pujol.   

Abstract

CKS1B is a member of the highly conserved cyclin kinase subunit 1 (CKS1) protein family which interacts with cyclin-dependent kinases and plays a critical role in cell cycle progression. In oral squamous cell carcinoma (OSCC), as in other malignancies, CKS1B overexpression has been correlated with reduced survival. To our knowledge, no studies evaluating the genetic status of CKS1B gene in OSCC have been reported. Herein, genetic and protein status of CKS1B were analyzed by immunohistochemical (IHC) and fluorescence in situ hybridization (FISH) techniques in a series of primary OSCC (n=51) and lymph node OSCC metastases samples (n=14). The observed results were compared with those obtained in either inflammatory (oral lichen planus [OLP]) (n=13) and premalignant oral mucosal lesions (oral leukoplakia) (n=16). A significant CKS1B overexpression was observed in OSCC and lymph node metastases samples than in OLP and oral leukoplakia (mean 70% vs 35%, p<0.001). CKS1B overexpression correlated with p27 loss of expression (p=0.0013) and SKP2 overexpression (p<0.00). FISH study disclosed statistical differences in both gene amplifications and gains between samples corresponding to OSCC and metastases from those of OLP and leukoplakia (p<0.001). Amplifications were present in 53% of OSCC samples and 33% of lymph node metastases vs 14% of oral leukoplakia and 0% of OLP biopsy specimens (p=0.002). Polysomies of chromosome 1 were seen in 46% of OSCC, 33% of ganglionar metastases, 14% of oral leukoplakia and 10% of OLP (p=0.036). Correlation of CKS1B over-expression and gains (both polysomies and amplifications) determined by FISH was statistically significant (p<0.001). Our results indicate that a high CKS1B expression is a common finding in primary OSCC which correlates with p27 low expression and SKP2 overexpression. This phenomenon may be due either to numerical (chromosome 1 polysomy) or structural (amplifications) CKS1B genetic abnormalities. This phenotypical and cytogenetic profile is not observed in premalignant or inflammatory oral mucosal lesions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21117028     DOI: 10.14670/HH-26.71

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  12 in total

1.  Identification of novel human kinases that suppress hepatitis C virus infection.

Authors:  A Lee; S Liu; T Wang
Journal:  J Viral Hepat       Date:  2013-11-10       Impact factor: 3.728

2.  Hypoxia drives transient site-specific copy gain and drug-resistant gene expression.

Authors:  Joshua C Black; Elnaz Atabakhsh; Jaegil Kim; Kelly M Biette; Capucine Van Rechem; Brendon Ladd; Paul D Burrowes; Carlos Donado; Hamid Mattoo; Benjamin P Kleinstiver; Bing Song; Grasiella Andriani; J Keith Joung; Othon Iliopoulos; Cristina Montagna; Shiv Pillai; Gad Getz; Johnathan R Whetstine
Journal:  Genes Dev       Date:  2015-05-15       Impact factor: 11.361

3.  Cks1: Structure, Emerging Roles and Implications in Multiple Cancers.

Authors:  Vinayak Khattar; Jaideep V Thottassery
Journal:  J Cancer Ther       Date:  2013-10-01

4.  Cks overexpression enhances chemotherapeutic efficacy by overriding DNA damage checkpoints.

Authors:  S V del Rincón; M Widschwendter; D Sun; S Ekholm-Reed; J Tat; L K Teixeira; Z Ellederova; E Grolieres; S I Reed; C Spruck
Journal:  Oncogene       Date:  2014-05-26       Impact factor: 9.867

Review 5.  Different Facets of Copy Number Changes: Permanent, Transient, and Adaptive.

Authors:  Sweta Mishra; Johnathan R Whetstine
Journal:  Mol Cell Biol       Date:  2016-01-11       Impact factor: 4.272

6.  Regulation of Transient Site-specific Copy Gain by MicroRNA.

Authors:  Joshua C Black; Hailei Zhang; Jaegil Kim; Gad Getz; Johnathan R Whetstine
Journal:  J Biol Chem       Date:  2016-01-11       Impact factor: 5.157

7.  p27Kip1 expression as a prognostic marker for squamous cell carcinoma of the head and neck.

Authors:  Miguel Reis DE Almeida; Mario Pérez-Sayáns; José Manuel Suárez-Peñaranda; José Manuel Somoza-Martín; Abel García-García
Journal:  Oncol Lett       Date:  2015-09-18       Impact factor: 2.967

8.  Increased expression of Cks1 protein is associated with lymph node metastasis and poor prognosis in nasopharyngeal carcinoma.

Authors:  Lina Xu; Songqing Fan; Jin Zhao; Peng Zhou; Shuzhou Chu; Jiadi Luo; Qiuyuan Wen; Lingjiao Chen; Sailan Wen; Li Wang; Lei Shi
Journal:  Diagn Pathol       Date:  2017-01-07       Impact factor: 2.644

9.  Genome wide analysis of chromosomal alterations in oral squamous cell carcinomas revealed over expression of MGAM and ADAM9.

Authors:  Vui King Vincent-Chong; Arif Anwar; Lee Peng Karen-Ng; Sok Ching Cheong; Yi-Hsin Yang; Padmaja Jayaprasad Pradeep; Zainal Ariff Abdul Rahman; Siti Mazlipah Ismail; Zuraiza Mohamad Zaini; Narayanan Prepageran; Thomas George Kallarakkal; Anand Ramanathan; Nur Aaina Binti Mohd Mohayadi; Nurul Shielawati Binti Mohamed Rosli; Wan Mahadzir Wan Mustafa; Mannil Thomas Abraham; Keng Kiong Tay; Rosnah Binti Zain
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  Clinicopathologic implications of the miR-197/PD-L1 axis in oral squamous cell carcinoma.

Authors:  Hyein Ahn; Jeong Mi Yang; Hyojin Kim; Jin-Haeng Chung; Soon-Hyun Ahn; Woo-Jin Jeong; Jin Ho Paik
Journal:  Oncotarget       Date:  2017-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.